UT Introduces UT Dell Medicine, Shares Plans for Advanced Specialty Care in Central Texas
On Oct. 27, 2026, the University of Texas at Austin introduced UT Dell Medicine, its academic health system,…
-
-
Lilly breaks ground in Richmond to expand next-generation cancer medicines
On Oct. 22, 2026, Eli Lilly broke ground on a new $5 billion manufacturing facility just west of…
-
Linda T. and John A. Mellowes Donate $50 Million to the Medical College of Wisconsin to Advance Precision Medicine
On Oct. 19, 2026, The Medical College of Wisconsin (MCW) announced a historic $50 million gift from Linda…
-
Artificial Intelligence | Biotechnology | Cardiology | Diagnostics | Genomics | Medicine | Neurology | NIH | Oncology | Telemedicine
Georgia Tech Opens Super Computer to researchers nationwide
On Oct. 12, 2026, Georgia Tech announced it is opening a new frontier in scientific computing with Nexus,…
-
Tom Golisano Commits $225 Million to Six Additional Children’s Hospitals, Expanding Golisano Children’s Alliance to 21 Members Nationwide
On Sept. 10, 2026, philanthropist and entrepreneur Tom Golisano announced a $225 million investment in six children’s hospitals,…
-
Artificial Intelligence | Biotechnology | Infectious Disease | Medicine | Nanotechnology | Neurology | Oncology
U.S. Research Cuts Drive Scientists to Germany
On Sept. 8, 2026, Science funding cuts in the United States have led many researchers to seek out…
-
Lilly to acquire Merida Biosciences to advance treatments for serious autoimmune and allergic diseases for $2.875 billion in cash
On Aug. 31, 2026, Eli Lilly and Merida Biosciences, a biotechnology company advancing a new class of precision…
-
Northwestern to launch $30 million center to unlock genome’s hidden code
On Aug. 28, 2026, the U.S. National Science Foundation (NSF) announced it has awarded Northwestern University $30 million…
-
Biotechnology | CRO | Medicine
McKesson to Acquire Precision Medicine Group for $2.25 billion
On Aug. 25, 2026, McKesson announced that it signed a definitive agreement to acquire Precision Medicine Group, a…
-
Artificial Intelligence | Biotechnology | Clinical Research | Diagnostics | Disease | Medicine | Stem Cell | Therapeutics
New £20m MRC Hub to Transform Development of New Medicines using Stem Cells and AI
On Aug. 12, 2026, the Medical Research Council (MRC) announced a £20 million investment in a new Pre-clinical…
-
Biotechnology | Diagnostics | Infectious Disease | Medicine | Non-Profit Research | Pharmaceutical | Therapeutics | Vaccine | Women's Health
Gates Foundation provides $540 Million landmark grant to the Institute for Health Metrics and Evaluation
On Aug. 10, 2026, the Institute for Health Metrics and Evaluation (IHME), an independent research organization at the…
-
Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA
On Jul. 20, 2026, Bristol Myers Squibb announced it will expand its compute infrastructure to deploy an NVIDIA…
-
Lilly to acquire AtaiBeckley for $3.8 billion advancing therapies for treatment-resistant depression
On Jul. 16, 2026, Eli Lilly and AtaiBeckley, a clinical-stage biopharmaceutical company developing innovative therapeutics for mental health…
-
Artificial Intelligence | Biotechnology | CRISPR | CRO | Diagnostics | Genomics | Imaging | Infectious Disease | Medicine | Nanotechnology | Neurology | Oncology | Organoids | Pharmaceutical | Robotics | Stem Cell | Therapeutics | Vaccine | Veterinary | Women's Health
Anthropic debuts AI-driven pharma R&D tool, Claude Science
On Jul. 1, 2026, tech giant Anthropic announced it has extended its foray into the life sciences space…
-
Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera for $1 Billion
On Jun. 17, 2026, Biogen and RayThera, a private biotechnology company focused on discovering and developing small molecule…
-
Biotechnology | Diagnostics | Genomics | Infectious Disease | Medicine | Nanotechnology | Neurology | NIH | Non-Profit Research | Oncology | Pharmaceutical | Rare Disease | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Women's Health
Trump administration drops court fight to cap NIH payments for research overhead costs
On Apr. 8, 2026, the Trump administration will not be asking the Supreme Court to take up its…
-
Biogen to Acquire Apellis for $5.6 billion, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease
On Mar. 31, 2026, Biogen and Apellis Pharmaceuticals announced the companies have entered into a definitive agreement under…
-
Lilly to acquire Centessa Pharma to advance treatments for sleep-wake disorders in deal worth up to $7.8 Billion
On Mar. 31, 2026, Eli Lilly and Centessa Pharmaceuticals, a clinical-stage company developing a new class of medicines…
-
NIH-awarded life scientist Shu Xiaokun abruptly shifts research from US to China
On Mar. 20, 2026, the South China Morning Post reported that celebrated scientist Shu Xiaokun, Ph.D. leaves prestigious…
-
Agriculture | Artificial Intelligence | Biotechnology | Diagnostics | Environmental | FDA | Genomics | Imaging | Infectious Disease | Medical Device | Medicine | Nanotechnology | Neurology | NIH | Non-Profit Research | Oncology | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine | Veterinary | Women's Health
National survey of NIH-funded researchers shows precarious state of U.S. science — ‘This is like the Titanic’
On Mar. 19, 2026, a nationwide STAT survey of federally funded researchers reveals that, a year after Donald…
-
Biotechnology | Chemistry | Energy | Materials | Medicine
Failed experiment leads to surprise drug development breakthrough
On Mar. 12, 2026, scientists at the University of Cambridge announced they have developed a new way to…
-
Biotechnology | Diagnostics | Medical Device | Medicine | Neurology | Non-Profit Research | Oncology | Pharmaceutical | Radiology | Therapeutics
Mass General Brigham Receives Transformative $50 Million Gift to Shape Future of Cancer Research
On Mar. 12, 2026, Mass General Brigham (MGB) announced it has received a $50 million gift that will…
-
Artificial Intelligence | Biotechnology | Environmental | Imaging | Medicine | Nanotechnology | Neurology | NIH | Non-Profit Research
UNC-Chapel Hill announces plans to develop campus extension in Carolina North
On Jan. 21, 2026, the University of North Carolina at Chapel Hill announced the development of a new…
-
Biotechnology | Clinical Research | Diagnostics | FDA | Genomics | Infectious Disease | Medical Device | Medicine | Non-Profit Research | Oncology | Ophthalmogy | Organ Transplant | Pharmaceutical | Rare Disease | Therapeutics | U.S. Congress | Vaccine | Women's Health
U.S. healthcare spending soars to over $5 trillion in 2024
On Jan. 14, 2026, U.S. healthcare spending rose by 7.2% to $5.3 trillion in 2024 from $4.9 trillion…
-
Diagnostics | Disease | Medical Device | Medicine | NIH | Non-Profit Research | Oncology | Radiology | Therapeutics | U.S. Congress | Women's Health
American Cancer Society Reports a Milestone 70 Percent 5-Year Survival Rate for all Cancers Combined
On Jan. 13, 2026, The American Cancer Society (ACS) released Cancer Statistics, 2026, the organization’s annual report on cancer facts and trends. The findings show, for…
-
Novartis and U.S. government reach agreement on lowering drug prices
On Dec. 19, 2025, Novartis, a leading global innovative medicines company, announced it has reached an agreement with…
-
FDA | Medicine | Therapeutics
Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals
On Dec. 9, 2025, Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved the…
-
Disease | Infectious Disease | Measles | Medicine | Non-Profit Research | Therapeutics | Vaccine | WHO | Women's Health
Nearly one in five child deaths linked to growth failure
On Dec. 2, 2025, findings in the latest Global Burden of Disease 2023 study published in The Lancet…
-
Anonymous donor gifts $50M to help University of Washington train ‘unsung heroes’ of healthcare
On Dec. 1, 2025, in an unusual act of philanthropy, an anonymous donor has committed more than $50…
-
Artificial Intelligence | Biology | Diagnostics | Disease | Medicine | Pharmaceutical | Therapeutics
MIT scientists debut a generative AI model that could create molecules addressing hard-to-treat diseases
On Nov. 25, 2025, a team of Massachusetts Institute of Technology scientists reported that AI model BoltzGen generates…
